MedPath

KHK-6640

Generic Name
KHK-6640

A Repeated Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease

Phase 1
Completed
Conditions
Alzheimer Disease
Interventions
Drug: Placebo
First Posted Date
2017-03-28
Last Posted Date
2018-03-20
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
21
Registration Number
NCT03093519
Locations
🇯🇵

Closed information, Saitama, Japan

A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.

Phase 1
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: Placebo
First Posted Date
2015-03-04
Last Posted Date
2016-12-07
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
20
Registration Number
NCT02377713

A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease

Phase 1
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: Matching Placebo
First Posted Date
2014-04-30
Last Posted Date
2024-06-17
Lead Sponsor
Kyowa Kirin Co., Ltd.
Target Recruit Count
57
Registration Number
NCT02127476
Locations
🇳🇱

Department of Neurology and Alzheimer Center, VU University Medical Center, Amsterdam, Netherlands

🇳🇱

University Medical Centre Groningen (UMCG), Alzheimer Research Centre, Groningen, Netherlands

🇧🇪

UZ Gent, De Pintelaan 185, Gent, Belgium

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath